|
The Epilepsy Monitoring Unit uses video-EEG to aid detection of epileptic foci. Ictal-SPECT and MRI techniques identify patients who can benefit from epilepsy surgery. Typically patients are admitted for 3 to 7 days of inpatient monitoring by a multidisciplinary team before a decision is made on epilepsy surgery.
|
The Stroke Intermediate and Intensive Care Units provide for the severely ill. A team of neuroradiologists provide CT, MRI/MRA, fMRI, angiography/DSA facilities. The Neurology ward is designed with an "on-site" Cerebrovascular Laboratory to provide carotid duplex ultrasound and transcranial doppler facilities.
A multi-disciplinary Stroke Team cares for stroke patients using a Coordinated Stroke Care Pathway.
There is an active research programme, particularly in the treatment of acute stroke as well as in secondary prevention of stroke.
|
|
Based at the Neurodiagnostic Unit, neuro-technicians provide nerve conduction studies, electromyography, electroencephalography, magnetic stimulation and evoked potential studies, used particularly in the assessment of patients with weakness, sensory loss, peripheral nerve and muscle disease.
|
|
Diagnosis and treatment of excessive daytime sleepiness, in particular, Sleep Apnoea Syndrome and Narcolepsy are the focus of the Sleep Disorders service. Typically, patients are admitted in the evenings, monitored overnight in the Sleep Monitoring Unit and discharged in time for work the next morning.
|
Sleep Study - Volunteers Needed
We are looking for adult volunteers aged 50 years and above, with no Parkinson's Disease or sleep complaints for a research study on sleep patterns.
Volunteers will undergo:
1. A comprehensive sleep evaluation
2. An overnight sleep study
If you have any queries or would like to participate in this sleep study, please call: 6326 6202 (SGH Sleep Disorder Unit). | |
|
Many patients with primary and secondary tumours to the brain and spine seek care at SGH. After diagnosis, neurologists (including neuro-oncologists) work closely with neurosurgeons, neuroradiologists, neuropathologists, radiation therapists and oncologists. Neuro-oncologists in the department provide a chemotherapy service for primary brain tumours (e.g. gliomas, CNS lymphomas, medulloblastomas, germinomas etc).
|
Dementia from Alzheimer’s Disease and other causes is a growing problem, particularly with an ageing population. In order to provide better management, sub-speciality clinics staffed by dedicated clinicians, nurses and psychologists have been set-up. These are backed up by scientists and neuro-radiologists.
Parkinson's Disease is an important interest of the Department. New and innovative therapies, e.g. pallidotomy and transplantation are being evaluated. A Parkinson's Disease patient support group has been formed and meets regularly.
The provision of neurogenetic testing and counselling has been a joint effort with geneticists at SGH. A test for Hungtington's Disease prenatally, and in the presymptomatic carrier is available. Tests for other neurologic diseases are being developed.
|
Neurologic diseases are a leading cause of severe disability in adult Singaporeans. Many patients have disabilities causing weakness, falls, paralysis, slurred speech and difficulty with activities of daily living. Caring for relatives with such disabilities is often a sudden, unexpected burden for which families are often poorly prepared.
The Neurology ward has been adapted to offer "on-site" dedicated neuro-rehabilitation facilities integrating a team of physiotherapists, occupational therapists, speech therapists, dietitians, nurse clinicians and educators, neuropsychologists and doctors. Such facilities encourage therapists to help the patient and relatives to work together as a co-ordinated team.
| |
|